Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 4, 1998, Pages 451-459

  Knudsen, J D ^a   Frimodt Moller N ^a   Espersen, F ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL PERITONITIS; CONTROLLED STUDY; DRUG ELIMINATION; FEMALE; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PERITONEAL CAVITY; PHARMACODYNAMICS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ASCITIC FLUID; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; FEMALE; MICE; PENICILLIN G; PENICILLIN RESISTANCE; PENICILLINS; PERITONITIS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031971710     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.4.451     Document Type: Article

References (24)

1. Frimodt-Møller, N., Bentzon, M. W. & Thomsen, V. F. (1986). Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. Journal of Infectious Diseases 154, 511-7.
2. Frimodt-Møller, N. & Thomsen, V. F. (1987). The pneumococcus and the mouse protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamycin. Acta Pathologica Microbiologica et Immunologica Scandinavica B 95, 159-65.
3. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S. & Craig, W. A. (1988). Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 158, 831-47.
4. Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W. et al. (1989). Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. Journal of Infectious Diseases 159, 281-92.
5. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van den Berghe-van Raffe, M., Vink-van den Berg, J. C. & Michel, B. M. (1989). Impact of the dosage schedule on the efficacy of ceftazidime, gentamycin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. European Journal of Clinical Microbiology and Infectious Diseases 8, 878-87.
6. Drusano, G. L., Johnson, D. E., Rosen, M. & Standiford, H. C. (1993). Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37, 483-90.
7. Bakker-Woudenberg, I. A. J. M., van den Berg, J. C., Fontijne, P. & Michel, M. F. (1984). Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. European Journal of Clinical Microbiology 3, 131-5.
8. Frimodt-Møller, N., Bentzon, M. W. & Thomsen, V. F. (1987). Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone. Acta Pathologica Microbiologica et Immunologica Scandinavica B 95, 261-7.
9. Frimodt-Møller, N. & Thomsen, V. F. (1986). The pneumococcus and the mouse protection test: inoculum, dosage and timing. Acta Pathologica Microbiologica et Immunologica Scandinavica B 94, 33-7.
10. Cozens, R. M., Tuomanen, E., Tosch, W., Zak, O., Suter, J. & Tomasz, A. (1986). Evaluation of the bactericidal activity of β-lactam antibiotics on the slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy 29, 797-802.
11. Tuomanen, E., Cozens, R., Tosch, W., Zak, O. & Tomasz, A. (1986). The rate of killing of Escherichia coli by β-lactam antibiotics is strictly proportional to the rate of bacterial growth. Journal of General Microbiology 132, 1297-304.
12. Eagle, H. (1949). The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum. Journal of Experimental Medicine 90, 595-607.
13. Eagle, H. (1952). Experimental approach to the problem of treatment failure with penicillin. American Journal of Medicine 11, 389-99.
14. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van den Berg, J. C. & Michel, M. F. (1985). Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. Journal of Infectious Diseases 152, 373-8.
15. Davey, P. G., Barza, M. & Stuart, M. (1987). Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamycin, and imipenem: evidence for resistance to 'late' treatment of infections. Journal of Infectious Diseases 155, 518-23.
16. Davey, P., Barza, M. & Stuart, M. (1988). Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo. Journal of Antimicrobial Chemotherapy 21, 395-404.
17. Isenberg, H. D., Sampson-Scherer, J., Cleeland, R.,Titsworth, E., Beskid, G., Christenson, J. G. et al. (1992). Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections. Critical Reviews in Microbiology 10, 1-76.
18. Gerber, A. U., Greter, U., Segessenmann, C. & Kozak, S. (1993). The impact of the pre-treatment interval on antimicrobial efficacy in a biological model. Journal of Antimicrobial Chemotherapy 31, Suppl. D, 29-39.
19. Knudsen, J. D., Frimodt-Møller, N. & Espersen, F. (1995). Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 39, 1253-8.
20. Frimodt-Møller, N., Sebbesen, O. & Frølund Thomson, V. (1983). The pneumococcus and the mouse protection test: importance of the lag phase in vivo. Chemotherapy 29, 128-34.
21. Gerber, A. U. & Craig, W. A. (1984). Dosierungsintervall und in-vivo-wirkung von penicillin gegen pneumokokken. Schweizerische Medizinische Wochenschrift 114, 1758-60.
22. Reed, I. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27, 493-7.
23. Hakenbeck, R., Ellerbrock, H., Briese, T., Handwerger, S. & Tomasz, A. (1986). Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides in carrying the β-lactam binding site. Antimicrobial Agents and Chemotherapy 30, 553-8.
24. Eagle, H., Fleischman, R. & Musselman, A. D. (1950). Effect of schedule of administration on the therapeutic efficacy of penicillin. American Journal of Medicine 9, 280-99.